Sign in

CIK 0001682852

  • Large accelerated filer

Moderna, Inc.

Sign in to watch
Ticker
MRNA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
813467528
Phone
+1 617-714-6500
Business address
325 BINNEY STREET, CAMBRIDGE, MA, 02142
Former names
Moderna Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$50,775,837
in 5 filings, $50.8M under 10b5-1 plans

Net −$50,775,837. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-05-01 AFEYAN NOUBAR Director Sale 10b5-1 −3,982 $109.70 $437K 2,037,949
2024-05-01 AFEYAN NOUBAR Director Sale 10b5-1 −4,572 $110.42 $505K 2,033,377
2024-05-01 AFEYAN NOUBAR Director Sale 10b5-1 −4,246 $111.55 $474K 2,029,131
2024-05-01 AFEYAN NOUBAR Director Sale 10b5-1 −1,500 $112.77 $169K 2,027,631
2024-05-01 AFEYAN NOUBAR Director Sale 10b5-1 −700 $113.40 $79K 2,026,931
2024-04-24 AFEYAN NOUBAR Director Sale 10b5-1 −3,926 $107.16 $421K 2,053,005
2024-04-24 AFEYAN NOUBAR Director Sale 10b5-1 −5,821 $108.30 $630K 2,047,184
2024-04-24 AFEYAN NOUBAR Director Sale 10b5-1 −4,153 $109.04 $453K 2,043,031
2024-04-24 AFEYAN NOUBAR Director Sale 10b5-1 −1,100 $109.91 $121K 2,041,931
2024-04-17 AFEYAN NOUBAR Director Sale 10b5-1 −8,243 $103.10 $850K 2,063,688
2024-04-17 AFEYAN NOUBAR Director Sale 10b5-1 −6,475 $103.69 $671K 2,057,213
2024-04-17 AFEYAN NOUBAR Director Sale 10b5-1 −282 $104.49 $29K 2,056,931
2024-04-15 Hoge Stephen President Sale 10b5-1 −15,000 $105.02 $1.6M 1,486,241
2024-04-10 AFEYAN NOUBAR Director Sale 10b5-1 −6,351 $106.59 $677K 2,080,580
2024-04-10 AFEYAN NOUBAR Director Sale 10b5-1 −7,512 $107.31 $806K 2,073,068
2024-04-10 AFEYAN NOUBAR Director Sale 10b5-1 −748 $108.56 $81K 2,072,320
2024-04-10 AFEYAN NOUBAR Director Sale 10b5-1 −389 $109.36 $43K 2,071,931
2024-04-08 Mock James M Chief Financial Officer Sale 10b5-1 −705 $101.93 $72K 5,048
2024-04-05 Mock James M Chief Financial Officer Exercise or conversion 10b5-1 +1,453 5,753
2024-04-05 Mock James M Chief Financial Officer Exercise or conversion · Restricted Stock Units 10b5-1 −1,453 14,527

Page 32 of 38 · 743 trades